A WHO grade 4 diffuse glioma arising in the cerebral hemispheres. It is characterized by the presence of missense mutation of the H3-3A gene. The prognosis is poor. The disease is Experimental Factor Ontology identifier EFO_0021505 (diffuse hemispheric glioma, H3 G34-mutant).